NASDAQ:MNTA
Delisted
Momenta Pharmaceuticals Stock News
$52.48
+0 (+0%)
At Close: May 27, 2022
Momenta Pharmaceuticals Inc (MNTA) Q1 2020 Earnings Call Transcript
04:31am, Friday, 08'th May 2020
At this time, I would like to welcome everyone to the Momenta Pharmaceuticals First Quarter 2020 Earnings Teleconference call. At this time, I would like to turn the call over to our first host, Patt
Edited Transcript of MNTA earnings conference call or presentation 7-May-20 12:30pm GMT
02:11am, Friday, 08'th May 2020
Q1 2020 Momenta Pharmaceuticals Inc Earnings Call
Thursday's ETF with Unusual Volume: XSMO
05:04pm, Thursday, 07'th May 2020
The ETF is seeing unusually high volume in afternoon trading Thursday, with over 199,000 shares traded versus three month average volume of about 50,000....
Momenta Pharmaceuticals Q1 EPS $(0.340) Beats $(0.480) Estimate, Sales $8.700M Beat $4.330M Estimate
11:25am, Thursday, 07'th May 2020Momenta Pharmaceuticals Reports First Quarter 2020 Financial and Operating Results
11:00am, Thursday, 07'th May 2020
-- Top-line interim data from nipocalimab Vivacity-MG study expected by Q3 2020 -- -- Full data from Part B of Phase 1/2 study of M254 in ITP expected in Q3 2020 -- --.
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Is Momenta Pharmaceuticals’ (NASDAQ:MNTA) Share Price Gain Of 118% Well Earned?
01:55pm, Friday, 01'st May 2020
Unfortunately, investing is risky - companies can and do go bankrupt. But when you pick a company that is really...
Analysts Estimate Momenta Pharmaceuticals (MNTA) to Report a Decline in Earnings: What to Look Out for
04:33pm, Thursday, 30'th Apr 2020
Momenta (MNTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Momenta Pharmaceuticals (MNTA) to Report a Decline in Earnings: What to Look Out for
04:33pm, Thursday, 30'th Apr 2020
Momenta (MNTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Momenta Pharmaceuticals (MNTA) Scheduled to Post Earnings on Thursday
10:14am, Thursday, 30'th Apr 2020
Momenta Pharmaceuticals (NASDAQ:MNTA) is scheduled to post its quarterly earnings results before the market opens on Thursday, May 7th. Analysts expect Momenta Pharmaceuticals to post earnings of ($0.
Analysts Estimate Momenta Pharmaceuticals (MNTA) to Report a Decline in Earnings: What to Look Out for
12:00am, Thursday, 30'th Apr 2020Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Insider Jo Ann Beltramello Sells 1,219 Shares of Stock
09:46am, Wednesday, 29'th Apr 2020
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) insider Jo Ann Beltramello sold 1,219 shares of Momenta Pharmaceuticals stock in a transaction on Friday, April 24th. The stock was sold at an average price
Reviewing Momenta Pharmaceuticals (NASDAQ:MNTA) & AVITA MED LTD/S (NASDAQ:RCEL)
06:26am, Tuesday, 28'th Apr 2020
AVITA MED LTD/S (NASDAQ:RCEL) and Momenta Pharmaceuticals (NASDAQ:MNTA) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valu
Macquarie Group Ltd. Sells 4,694 Shares of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)
10:54am, Sunday, 26'th Apr 2020
Macquarie Group Ltd. cut its holdings in shares of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) by 2.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Comm
